CochLear (OTCMKTS:CHEOY) Stock Rating Lowered by Zacks Research

CochLear (OTCMKTS:CHEOY) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Monday,Zacks.com reports.

Separately, UBS Group cut CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

CochLear Stock Up 3.0%

Shares of OTCMKTS:CHEOY opened at $37.83 on Monday. The stock’s 50-day moving average price is $41.45 and its 200-day moving average price is $66.16. CochLear has a 12-month low of $31.82 and a 12-month high of $105.60.

CochLear Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.